Cargando…

The Impact of Cholesterol, DHA, and Sphingolipids on Alzheimer's Disease

Alzheimer's disease (AD) is a devastating neurodegenerative disorder currently affecting over 35 million people worldwide. Pathological hallmarks of AD are massive amyloidosis, extracellular senile plaques, and intracellular neurofibrillary tangles accompanied by an excessive loss of synapses....

Descripción completa

Detalles Bibliográficos
Autores principales:	Grimm, Marcus O. W., Zimmer, Valerie C., Lehmann, Johannes, Grimm, Heike S., Hartmann, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929518/ https://www.ncbi.nlm.nih.gov/pubmed/24575399 http://dx.doi.org/10.1155/2013/814390

Ejemplares similares

Effect of Different Phospholipids on α-Secretase Activity in the Non-Amyloidogenic Pathway of Alzheimer’s Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2013)

The Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´s Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2016)

Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer’s Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2013)

Tocotrienol Affects Oxidative Stress, Cholesterol Homeostasis and the Amyloidogenic Pathway in Neuroblastoma Cells: Consequences for Alzheimer’s Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2016)

Vitamin D and Its Analogues: From Differences in Molecular Mechanisms to Potential Benefits of Adapted Use in the Treatment of Alzheimer’s Disease
por: Thiel, Andrea, et al.
Publicado: (2023)

Methylxanthines and Neurodegenerative Diseases: An Update
por: Janitschke, Daniel, et al.
Publicado: (2021)

Sphingolipids and DHA Improve Cognitive Deficits in Aged Beagle Dogs
por: Araujo, Joseph A., et al.
Publicado: (2022)

The impact of capsaicinoids on APP processing in Alzheimer’s disease in SH-SY5Y cells
por: Grimm, Marcus O. W., et al.
Publicado: (2020)

Role of cholesterol and sphingolipids in brain development and neurological diseases
por: Hussain, Ghulam, et al.
Publicado: (2019)

The Equilibria of Sphingolipid-Cholesterol and Sphingolipid–Sphingolipid in Monolayers at the Air–Water Interface
por: Petelska, Aneta Dorota, et al.
Publicado: (2012)

APP Function and Lipids: A Bidirectional Link
por: Grimm, Marcus O. W., et al.
Publicado: (2017)

Plasmalogens Inhibit APP Processing by Directly Affecting γ-Secretase Activity in Alzheimer's Disease
por: Rothhaar, Tatjana L., et al.
Publicado: (2012)

Interprofessional education: a necessity in Alzheimer’s dementia care—a pilot study
por: Dressel, Katharina, et al.
Publicado: (2023)

Intracellular APP Domain Regulates Serine-Palmitoyl-CoA Transferase Expression and Is Affected in Alzheimer's Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2011)

Shotgun lipidomics of liver and brain tissue of Alzheimer’s disease model mice treated with acitretin
por: Lauer, Anna A., et al.
Publicado: (2021)

Amyloid Precursor Protein (APP) Mediated Regulation of Ganglioside Homeostasis Linking Alzheimer's Disease Pathology with Ganglioside Metabolism
por: Grimm, Marcus O. W., et al.
Publicado: (2012)

Cholesterol and Sphingolipid Enriched Lipid Rafts as Therapeutic Targets in Cancer
por: Codini, Michela, et al.
Publicado: (2021)

Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer’s disease
por: Patrick, Rhonda P.
Publicado: (2019)

Mechanistic Link between Vitamin B12 and Alzheimer’s Disease
por: Lauer, Anna Andrea, et al.
Publicado: (2022)

Targeted Lipidomics of Mitochondria in a Cellular Alzheimer’s Disease Model
por: Kurokin, Irina, et al.
Publicado: (2021)

Impact of DHA on Metabolic Diseases from Womb to Tomb
por: Arnoldussen, Ilse A. C., et al.
Publicado: (2014)

Regulatory feedback cycle of the insulin‐degrading enzyme and the amyloid precursor protein intracellular domain: Implications for Alzheimer’s disease
por: Lauer, Anna A., et al.
Publicado: (2020)

Interdisciplinary Approaches to Deal with Alzheimer’s Disease—From Bench to Bedside: What Feasible Options Do Already Exist Today?
por: Ablinger, Irene, et al.
Publicado: (2022)

Upregulation of PGC-1α expression by Alzheimer’s disease-associated pathway: presenilin 1/amyloid precursor protein (APP)/intracellular domain of APP
por: Robinson, Ari, et al.
Publicado: (2014)

Marine Sources of DHA-Rich Phospholipids with Anti-Alzheimer Effect
por: Ferreira, Inês, et al.
Publicado: (2022)

Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases
por: Fantini, Jacques, et al.
Publicado: (2010)

Erythrocyte sphingolipid species as biomarkers of Alzheimer's disease
por: Mill, Jericha, et al.
Publicado: (2022)

Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer’s Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue
por: Heath, Rory J., et al.
Publicado: (2021)

APP intracellular domain derived from amyloidogenic β- and γ-secretase cleavage regulates neprilysin expression
por: Grimm, Marcus O. W., et al.
Publicado: (2015)

Unique Role of Caffeine Compared to Other Methylxanthines (Theobromine, Theophylline, Pentoxifylline, Propentofylline) in Regulation of AD Relevant Genes in Neuroblastoma SH-SY5Y Wild Type Cells
por: Janitschke, Daniel, et al.
Publicado: (2020)

EPA and DHA differentially modulate membrane elasticity in the presence of cholesterol
por: Jacobs, Miranda L., et al.
Publicado: (2021)

Sphingolipid Domains in the Plasma Membranes of Fibroblasts Are Not Enriched with Cholesterol
por: Frisz, Jessica F., et al.
Publicado: (2013)

A Synergistic Combination of DHA, Luteolin, and Urolithin A Against Alzheimer’s Disease
por: Jayatunga, Dona P. W., et al.
Publicado: (2022)

The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer’s disease
por: Yassine, Hussein N., et al.
Publicado: (2016)

Structure and Nanomechanics of Model Membranes by Atomic Force Microscopy and Spectroscopy: Insights into the Role of Cholesterol and Sphingolipids
por: Gumí-Audenis, Berta, et al.
Publicado: (2016)

Gemfibrozil-Induced Intracellular Triglyceride Increase in SH-SY5Y, HEK and Calu-3 Cells
por: Bachmann, Cornel Manuel, et al.
Publicado: (2023)

The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer’s Disease
por: de Wit, Nienke M., et al.
Publicado: (2021)

Sphingolipids in COPD
por: Chakinala, Raja Chandra, et al.
Publicado: (2019)

Cholesterol Balance in Prion Diseases and Alzheimer’s Disease
por: Hannaoui, Samia, et al.
Publicado: (2014)

Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration
por: Ayub, Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_57tuj4a00mjdbcjkanlhk9446n